Abstract

One titrimetric and two spectrophotometric methods are proposed for the determination of diethylcarbamazine citrate (DEC) in bulk drug and in formulations using potassium iodate and potassium iodide as reagent. The methods employ the well-known analytical reaction between iodate and iodide in the presence of acid. In titrimetry (method A), the drug was treated with a measured excess of thiosulfate in the presence of unmeasured excess of iodate-iodide mixture and after a standing time of 10 min, the surplus thiosulfate was determined by back titration with iodine towards starch end point. Titrimetric assay is based on a 1:3 reaction stoichiometry between DEC and iodine and the method is applicable over 2.0-10.0 mg range. The liberated iodine is measured spectrophotometrically at 370 nm (method B) or the iodine-starch complex measured at 570 nm (method C). In both methods, the absorbance is found to be linearly dependent on the concentration of iodine, which in turn is related to DEC concentration. The calibration curves are linear over 2.5-50 and 2.5-30 µg mL-1 DEC for method B and method C, respectively. The calculated molar absorptivity and Sandell sensitivity values were 6.48×103 L mol-1 cm-1 and 0.0604 µg cm-2, respectively, for method B, and their respective values for method C are 9.96×103 L mol-1 cm-1 and 0.0393 µg cm-2. The intra-day and inter-day accuracy and precision studies were carried out according to the ICH guidelines. The methods were successfully applied to the analysis of DEC formulations.

Highlights

  • Diethylcarbamazine citrate (DEC) [Figure 1], chemically known as [N,N-diethyl-4-methyl-1piperazinecarboxamide citrate] is an anthelmintic agent used in the treatment of filarial infections caused by a host of organisms commonly found in the tropics (Swinyard, 1990)

  • Preliminary experiments showed that DEC is sufficiently acidic to release iodine from iodate-iodide mixture allowing the titrimetric and spectrophotometric determination of drug

  • The liberated iodine was reacted with a measured excess of thiosulphate and residual reductant was titrated with iodine and the end point being located visually with starch, while in spectrophotometry, it was determined by two different color reactions

Read more

Summary

Introduction

Diethylcarbamazine citrate (DEC) [Figure 1], chemically known as [N,N-diethyl-4-methyl-1piperazinecarboxamide citrate] is an anthelmintic agent used in the treatment of filarial infections caused by a host of organisms commonly found in the tropics (Swinyard, 1990) It is the alternative drug of choice in Onchocerca volvulus infections and tropical eosinophilia (Adkiwu, Ofokansi, Attama, 1999). Other than these official methods, a variety of techniques have been reported for the determination of DEC in pharmaceutical dosage forms, and include gas chromatography [GC] (Ramana, Raghuveer, Khadgapathi, 1986; Nene, Anjaneyalu, Rajagopalan, 1984; Pfaff, Gayral, Mahuzier, 1978; Joseph, Lawrence, 2001), high performance liquid chromatography [HPLC] (Mathew, Kalyanasundaram, 2001; Reddy et al, 2011; Krishna Vamsi et al, 2012), proton magnetic resonance [PMR] spectroscopy (El-Obeid, 1984, Jezzy et al, 1996), DC polarography analysis (Walash et al, 1985), ion selective electrode potentiometry (Campbell et al, 1980) and titrimetry (Abigail et al, 2011; Bhanumathi et al, 1981). The need for a simple, selective and low-cost method is obvious, especially for routine quality control analysis of pharmaceuticals containing DEC

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call